IRME — IR-MED Cashflow Statement
0.000.00%
Last trade - 00:00- $2.35m
- $2.49m
Annual cashflow statement for IR-MED, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.752 | -3.72 | -4.73 | -4.91 | -1.9 |
| Depreciation | |||||
| Non-Cash Items | 0.025 | 1.35 | 1.3 | 1.68 | 0.487 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.324 | -0.121 | 0.047 | -0.019 | 0.005 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.402 | -2.48 | -3.38 | -3.23 | -1.39 |
| Capital Expenditures | — | -0.031 | -0.05 | -0.002 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -0.03 | -0.009 | 0 | — |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | — | -0.061 | -0.059 | -0.002 | — |
| Financing Cash Flow Items | 1.96 | 3.49 | 3.63 | 1 | 0.755 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.04 | 3.49 | 3.63 | 1 | 0.75 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.63 | 0.949 | 0.187 | -2.23 | -0.638 |